| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 31.91M | 38.61M | 44.91M | 55.01M | 48.67M | 39.38M |
| Gross Profit | 26.33M | 33.44M | 38.72M | 48.65M | 42.38M | 34.42M |
| EBITDA | -6.05M | -3.56M | -9.20M | 5.35M | 1.25M | 947.00K |
| Net Income | -9.90M | -8.19M | -10.89M | 2.94M | 1.60M | -232.00K |
Balance Sheet | ||||||
| Total Assets | 11.20M | 12.41M | 22.38M | 37.42M | 34.64M | 34.59M |
| Cash, Cash Equivalents and Short-Term Investments | 355.00K | 570.00K | 1.37M | 7.59M | 10.02M | 16.83M |
| Total Debt | 2.31M | 1.16M | 2.02M | 3.11M | 2.21M | 3.17M |
| Total Liabilities | 10.22M | 8.86M | 10.54M | 14.60M | 15.01M | 17.13M |
| Stockholders Equity | 984.00K | 3.55M | 11.84M | 22.81M | 19.63M | 17.45M |
Cash Flow | ||||||
| Free Cash Flow | -113.00K | 431.00K | -4.90M | -1.50M | -5.79M | 2.19M |
| Operating Cash Flow | -65.00K | 1.93M | -665.00K | 3.63M | 352.00K | 5.41M |
| Investing Cash Flow | -978.00K | -1.50M | -4.20M | -5.07M | -6.13M | -3.20M |
| Financing Cash Flow | -713.00K | -1.10M | -1.26M | -1.32M | -1.20M | -1.03M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | £2.97B | 19.41 | 16.69% | 1.27% | 0.84% | -62.73% | |
76 Outperform | £2.14B | 13.52 | 20.62% | 2.58% | 11.42% | -17.18% | |
65 Neutral | £5.59B | 21.21 | 31.07% | 3.44% | 1.14% | 17.74% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | £285.74M | -3.42 | -12.22% | 15.28% | -3.91% | -310.36% | |
44 Neutral | £12.54M | -1.51 | -168.28% | ― | -27.82% | -3083.87% | |
41 Neutral | £284.37M | -2.81 | -142.88% | ― | -4.87% | ― |